logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Joseph S. Ross

rollins school public health

84H指数
1.0K论文数
3.0W被引数
收录论文 469
发表时间
logo
Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetesGLP-1受体激动剂、SGLT 2抑制剂、DPP-4抑制剂和磺脲类药物与2型糖尿病患者新发癌症的关联
errDiabetes Research and Clinical Practice
IF7.4
err2026-08-17
err0
errOAAI
errStacey M. Sklepinski; Jeph Herrin; Kavya Sindhu Swarna; Joshua J. Neumiller; Rodolfo J. Galindo; Guillermo E. Umpierrez; Joseph S. Ross; Yihong Deng; Eric C. Polley; Mindy M. Mickelson; Rozalina G. McCoy
err分享
err收藏
Orphan Designation for Drugs Approved in the United States and European Union: A Comparative Analysis美国和欧洲联盟批准药物的罕见病药物认定：一项比较分析
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2026-05-31
err0
PREAI
errEnrico Costa; Joseph S. Ross; Aaron S. Kesselheim
err分享
err收藏
Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study阿格列汀、利格列汀、沙格列汀和西格列汀的心血管效应：一项比较疗效研究的靶试验模拟研究
errEndocrine Practice
IF4.6
err2026-04-08
err0
PREAI
errUrja N. Kalathiya; Kimberly Yuang; Jeph Herrin; Kavya Sindhu Swarna; Yihong Deng; Eric C. Polley; Joshua J. Neumiller; Rodolfo J. Galindo; Guillermo E. Umpierrez; Joseph S. Ross; Juan P. Brito; Victor M. Montori; Bijan J. Borah; Bradley A. Maron; Mindy M. Mickelson; Rozalina G. McCoy
err分享
err收藏
Surrogate markers used as efficacy endpoints in NIH-sponsored clinical trialsNIH资助的临床试验中用作疗效终点的替代标志物
errClinical Trials
IF2.2
err2026-01-01
err0
PREAI
errMohammad, Ayman; Yoon, Samuel; Wallach, Joshua D.; Ramachandran, Reshma; Ross, Joseph S.
err分享
err收藏
Automatic Medicare Coverage for New Medical Technologies - Here We Go Again新医疗技术自动医疗保险覆盖——我们再次面临挑战
errNew England Journal of Medicine
IF78.5
err2026-01-01
err1
PREAI
errKadakia, Kushal T.; Dhruva, Sanket S.; Ross, Joseph S.; Rathi, Vinay K.
err分享
err收藏
Enhancing FDA Drug-Safety Surveillance - Beyond Releasing Daily Adverse-Event Data增强FDA药物安全监测——超越发布每日不良事件数据
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-12-01
err1
PREAI
errWallach, Joshua D.; Ross, Joseph S.; Ramachandran, Reshma
err分享
err收藏
Patient and public involvement and engagement in methodology research: process, experiences, and recommendations from the SPIRIT- and CONSORT-Surrogate project患者与公众参与及在方法论研究中的投入：SPIRIT-和CONSORT-Surrogate项目的过程、经验与建议
errRESEARCH INVOLVEMENT AND ENGAGEMENT
IF0
err2025-12-01
err1
PREAI
errManyara, Anthony Muchai; Stewart, Derek; Markham, Sarah; Worrall, Andrew; Harris, Ray; Davies, Philippa; Weir, Christopher J.; Young, Amber E.; Blazeby, Jane; Butcher, Nancy J.; Bujkiewicz, Sylwia; Chan, An-Wen; Dawoud, Dalia; Offringa, Martin; Ouwens, Mario; Collins, Gary S.; Ross, Joseph S.; Taylor, Rod S.; Ciani, Oriana
err分享
err收藏
Flexibility over rigor: stakeholder acceptance of the limitations of confirmatory studies following accelerated approval
errHealth Affairs Scholar
IF0
err2025-11-01
err0
errOAAI
errLynch, Holly Fernandez; Lee, Sejin; Herder, Matthew; Ross, Joseph S.; Ramachandran, Reshma
err分享
err收藏
Trends in Nonresearch Industry Payments to Emergency Physicians Between 2016 and 20232016年至2023年间非研究性行业对急诊科医生的付款趋势
errAnnals of Emergency Medicine
IF5
err2025-10-10
err0
PREAI
errDalia Owda; Constantin Radu; Joseph S. Ross; Craig Rothenberg; Arjun K. Venkatesh
err分享
err收藏
Identifying common patterns in journals that retracted papers from paper mills: a cross-sectional study识别论文工厂撤稿期刊中常见模式：一项横断面研究
errResearch Integrity and Peer Review
IF10.7
err2025-10-02
err0
errOAAI
errNoa Mascato Fontaíña; Cristina Candal-Pedreira; Guadalupe García; Joseph S. Ross; Alberto Ruano-Ravina; Lucía Martin-Gisbert
err分享
err收藏
Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid医疗保健和医疗补助计划覆盖的最昂贵药物的治疗效益
errJournal of Pharmaceutical Policy and Practice
IF2.5
err2025-10-01
err0
errOAAI
errTiffany Enxia Jiang; Reshma Ramachandran; Kerstin N. Vokinger; Joseph S. Ross
err分享
err收藏
Confirmatory evidence supporting single pivotal trial new drug approvals by the Food and Drug Administration, 2015 through 2023支持食品药品监督管理局（Food and Drug Administration）2015年至2023年间通过单一关键性试验批准新药的确认性证据
errCLINICAL TRIALS
IF2.2
err2025-10-01
err0
PREAI
errGodoy, Carla Barile; Ramachandran, Reshma; Sapre, Pradyumna; Ross, Joseph S.
err分享
err收藏
Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trialGLP-1受体激动剂在具有中度心血管风险的2型糖尿病成人中对心血管结局的相对有效性：目标试验的模拟研究
errDiabetes Research and Clinical Practice
IF7.4
err2025-09-20
err0
errOAAI
errStacey M. Sklepinski; Yihong Deng; Kavya Sindu Swarna; Jeph Herrin; Eric C. Polley; Joshua J. Neumiller; Rodolfo J. Galindo; Guillermo E. Umpierrez; Joseph S. Ross; Bijan J. Borah; Bradley A. Maron; Mindy M. Mickelsonb; Rozalina G. McCoy
err分享
err收藏
Reusing clinical trial data to consolidate and advance medical knowledge重复使用临床试验数据以巩固和推进医学知识
errJournal of Clinical Epidemiology
IF5.2
err2025-09-19
err0
PREAI
errGiulia Varvarà; Cora Burgwinkel; Clara Locher; Joseph S. Ross; Ulrich Mansmann; Florian Naudet
err分享
err收藏
Association Between Usual Clinician Presence and Emergency Department Revisitation临床医师常规在岗与急诊科再次就诊之间的关联
errJournal of the American Geriatrics Society
IF4.5
err2025-09-12
err0
PREAI
errDoreen S. Agboh; Arjun K. Venkatesh; Yixuan Liang; Wafa Salah; Craig Rothenberg; Joseph S. Ross; Ishani Ganguli; Cameron J. Gettel
err分享
err收藏
Comparative Risk of Adverse Pancreatic Events with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas among Adults with Type 2 Diabetes at Moderate Cardiovascular Disease RiskGLP-1受体激动剂、SGLT2抑制剂、DPP4抑制剂和磺脲类药物在具有中度心血管疾病风险的2型糖尿病成人中不良胰腺事件的比较风险
errEndocrine Practice
IF4.6
err2025-09-11
err0
PREAI
errUrja N. Kalathiya; Jeph Herrin; Kavya Sindu Swarna; Yihong Deng; Eric C. Polley; Joshua J. Neumiller; Rodolfo J. Galindo; Guillermo E. Umpierrez; Joseph S. Ross; Mindy M. Mickelson; Rozalina G. McCoy
err分享
err收藏
Use of FDA Expedited Programs and Development Timelines for New Molecular Entity Drug and New Biologic Approvals by Sponsor Experience使用FDA加速计划及新分子实体药物和新生物制品审批的开发时间线与申办方经验
errClinical Pharmacology & Therapeutics
IF5.5
err2025-09-05
err0
PREAI
errKanhai S. Amin; Bhav Jain; Alissa Wong; Joseph S. Ross
err分享
err收藏
Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis2017年至2021年中国癌症药物审批的证据强度：一项回顾性分析
errlancet oncology
IF0
err2025-08-06
err0
PREAI
errYichen Zhang; Dingyi Chen; Mengyuan Fu; Luwen Shi; Huseyin Naci; Anita K Wagner; Joseph S Ross; Xiaodong Guan
err分享
err收藏
Risk of Sight-Threatening Diabetic Retinopathy With GLP-1 RA Use in Routine Clinical Practice: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide使用GLP-1 RA治疗在常规临床实践中导致视力威胁性糖尿病视网膜病变的风险：司美格鲁肽、度拉糖肽、利拉鲁肽和艾塞那肽的疗效比较
errOphthalmology Retina
IF5.7
err2025-08-06
err0
PREAI
errAndrew J. Barkmeier; Yihong Deng; Kavya Sindhu Swarna; Jeph Herrin; Eric C. Polley; Guillermo E. Umpierrez; Rodolfo J. Gallindo; Joseph S. Ross; Mindy M. Mickelson; Rozalina G. McCoy
err分享
err收藏
Anticoagulation therapy for patients with atrial fibrillation at primary care facilities in Beijing, China, 2017–20222017—2022年中国北京基层医疗机构心房颤动患者抗凝治疗情况
errThrombosis Research
IF3.4
err2025-08-01
err0
PREAI
errMengyuan Fu; Kexin Ling; Zhiwen Gong; Shujie Dong; Huangqianyu Li; Fang Wang; Yang Xu; Luwen Shi; Joseph S. Ross; Xiaodong Guan
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
R
Ralph B. D’Agostino
H 指数: 236 · 论文数: 2.0K
J
John P. A. Ioannidis
H 指数: 226 · 论文数: 1.9K
H
Harlan M. Krumholz
H 指数: 216 · 论文数: 2.8K
D
David Moher
H 指数: 214 · 论文数: 1.5K
G
Gregg C. Fonarow
H 指数: 198 · 论文数: 3.0K
查看更多